Catalyst Wire Dossier Catalyst Wire Dossier

Brivanib

brivanib · Bristol-Myers Squibb
Drug timelines are a Plus or Pro feature.

14 regulatory and trial events tracked for Brivanib, covering 2009-01-22 to 2024-07-23. Get the full timeline:

Most recent: Clinical Trial Update: MGD013 Monotherapy and Combination With Brivanib Dose Escalation and Expansion Study in Advanced Liver Cancer Patients [Phase 1, Phase 2]

See pricing